| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.15B | $1.04B | $910.5M |
| YoY Revenue Growth % | +10.3% | +14.4% | — |
| Gross Profit | $632.9M | $564.4M | — |
| Gross Margin % | 55.1% | 54.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $28.9M | -$51.3M | -$98.6M |
| Operating Margin % | 2.5% | -4.9% | -10.8% |
| Net Income (GAAP) | $39.4M | -$12.8M | -$81.8M |
| EBITDA (Normalized) | $48.8M | -$17.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $226.2M | $143.2M | $128.8M |
| Capital Expenditures (CapEx) | $25.0M | $42.4M | — |
| Free Cash Flow (FCF) | $201.2M | $100.8M | $128.8M |
| FCF Margin % | 17.5% | 9.7% | 14.2% |
| Return on Invested Capital (ROIC %) | 4.1% | -15.6% | — |
| Cash & Short-Term Equivalents | $232.1M | $362.5M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $785.8M | $622.2M | — |